Last reviewed · How we verify
Systemic Juvenile Idiopathic Arthritis
Approved treatments
- tocilizumab or sarilumab · Pfizer
- tocilizumab or sarilumab · Pfizer
- tocilizumab or sarilumab · Pfizer
- tocilizumab or sarilumab · Pfizer
- tocilizumab or sarilumab · Pfizer
- tocilizumab or sarilumab · Pfizer
- tocilizumab or sarilumab · Pfizer
- tocilizumab or sarilumab · Pfizer
- tocilizumab or sarilumab · Pfizer
- tocilizumab or sarilumab · Pfizer
- tocilizumab or sarilumab · Pfizer
- tocilizumab or sarilumab · Pfizer
- tocilizumab or sarilumab · Pfizer
- tocilizumab or sarilumab · Pfizer
- tocilizumab or sarilumab · Pfizer
- tocilizumab or sarilumab · Pfizer
- tocilizumab or sarilumab · Pfizer
- tocilizumab or sarilumab · Pfizer
- tocilizumab or sarilumab · Pfizer
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Systemic Juvenile Idiopathic Arthritis patent landscape — cliff calendar, originator estates, attackable patents
- Systemic Juvenile Idiopathic Arthritis treatment landscape brief
- Systemic Juvenile Idiopathic Arthritis treatment updates RSS
Frequently asked questions about Systemic Juvenile Idiopathic Arthritis
What drugs treat Systemic Juvenile Idiopathic Arthritis?
Tracked treatments include tocilizumab or sarilumab.
What is the treatment for Systemic Juvenile Idiopathic Arthritis?
Standard treatment for Systemic Juvenile Idiopathic Arthritis includes tocilizumab or sarilumab. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Systemic Juvenile Idiopathic Arthritis patent cliff · Systemic Juvenile Idiopathic Arthritis CI report
- Treatment: tocilizumab or sarilumab · Pfizer
- Treatment: tocilizumab or sarilumab · Pfizer
- Treatment: tocilizumab or sarilumab · Pfizer
- Treatment: tocilizumab or sarilumab · Pfizer
- Treatment: tocilizumab or sarilumab · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing